Researchers identify two new AMD drug candidates using a stem-cell-derived model

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

Related Keywords

New York ,United States ,Kapil Bharti ,Ruchi Sharma ,Michaelf Chiang ,Emily Henderson ,Nature Communications ,Stem Cell Translational Research Section ,York Stem Cell Foundation ,National Eye Institute ,National Institutes Of Health ,Merck Co ,Intramural Research Program ,National Institutes ,New York Stem Cell ,Cell ,Drugs ,Research ,Age Related Macular Degeneration ,Aging ,Blindness ,Flood ,Cytoskeleton ,Diet ,Eye ,Enetic ,Inflammation ,Macular Degeneration ,Medical Research ,Utation ,Mh ,Henotype ,Smoking ,